Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide–Target Interactions
Authors:
- 10 January 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (2) , 1083-1111
Abstract
The activation of G protein-coupled receptors (GPCRs) is triggered by ligand binding to their orthosteric sites, which induces ligand-specific conformational changes. Agonists and antagonists bound to GPCR orthosteric sites provide detailed information on ligand-binding modes. Among these, peptide ligands play an instrumental role in GPCR pharmacology and have attracted increased attention as therapeutic drugs. The recent breakthrough in GPCR structural biology has resulted in the remarkable availability of peptide-bound GPCR complexes. Despite the several structural similarities shared by these receptors, they exhibit distinct features in terms of peptide recognition and receptor activation. From this perspective, we have summarized the current status of peptide-bound GPCR structural complexes, largely focusing on the interactions between the receptor and its peptide ligand at the orthosteric site. In-depth structural investigations have yielded valuable insights into the molecular mechanisms underlying peptide recognition. This study would contribute to the discovery of GPCR peptide drugs with improved therapeutic effects.Keywords
Funding Information
- Shanghai Jiao Tong University
- National Natural Science Foundation of China (22077082)
- Human Diseases, and Innovative Research Team of High-Level Local Universities in Shanghai
This publication has 156 references indexed in Scilit:
- The kallikrein–kinin system in diabetic nephropathyKidney International, 2012
- Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug DesignJournal of Medicinal Chemistry, 2012
- Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptorsActa Pharmacologica Sinica, 2012
- High-fat intake induced by mu-opioid activation of the nucleus accumbens is inhibited by Y1R-blockade and MC3/4R- stimulationBrain Research, 2010
- Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 ReceptorJournal of Biological Chemistry, 2010
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- Function, structure and therapeutic potential of complement C5a receptorsBritish Journal of Pharmacology, 2007
- Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptorProceedings of the National Academy of Sciences, 2007
- Substance P and its receptor neurokinin 1 expression in asthmatic airwaysJournal of Allergy and Clinical Immunology, 2000
- Molecular cloning of a levocabastine‐sensitive neurotensin binding siteFEBS Letters, 1996